Form D — SYNTIS BIO, INC.
0001943061-25-000005 · filed 2025-07-02
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $26,483,445
- Total sold
- $24,983,429
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- SYNTIS BIO, INC.
- CIK
- 1943061
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2022
- Address
- 135 MORRISSEY BLVD
BOSTON, MA 02125 - Phone
- 857-675-1109
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Rahul Dhanda · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Robert Langer · DirectorBoston, MA Find on LinkedIn ↗
-
Carlo Giovanni Traverso · DirectorBoston, MA Find on LinkedIn ↗
-
Teymour Boutros-Ghali · DirectorBoston, MA Find on LinkedIn ↗
-
Martin Madaus · DirectorBoston, MA Find on LinkedIn ↗
-
Teymour Boutros-Ghali · DirectorBoston, MA Find on LinkedIn ↗
-
Chenny Zhang · DirectorBoston, MA Find on LinkedIn ↗
-
Michael Nannizzi · DirectorBoston, MA Find on LinkedIn ↗
View original on SEC EDGAR.